Macrolide-Resistant Mycoplasma pneumoniae, United States

• Published in: Emerging infectious diseases Vol. 21; no. 8; pp. 1470 - 1472
• Main Authors: Zheng, Xiaotian, Lee, Stella, Selvarangan, Rangaraj, Qin, Xuan, Tang, Yi-Wei, Stiles, Jeffrey, Hong, Tao, Todd, Kathleen, Ratliff, Amy E, Crabb, Donna M, Xiao, Li, Atkinson, T Prescott, Waites, Ken B
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01.08.2015; Centers for Disease Control and Prevention
• Subjects: Adolescent; Adult; Aged; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; antimicrobial resistance; Child; Child, Preschool; children; Dispatch; Drug Resistance, Bacterial - drug effects; Drug Resistance, Bacterial - genetics; Drug therapy; Forecasts and trends; Humans; Infant; macrolide; Macrolide-Resistant; Macrolides; Macrolides - therapeutic use; Medical research; MIC; Microbial drug resistance; Microbial Sensitivity Tests - utilization; Middle Aged; Mycoplasma infections; Mycoplasma pneumoniae; Mycoplasma pneumoniae - drug effects; Mycoplasma pneumoniae - genetics; Mycoplasma pneumoniae - immunology; Patient outcomes; Pneumonia, Mycoplasma - epidemiology; Precision medicine; United States; United States - epidemiology; United States; bacteria; United States; antimicrobial resistance; children; MIC; Mycoplasma pneumoniae; macrolide
• ISSN: 1080-6040; 1080-6059; 1080-6059
• DOI: 10.3201/eid2108.150273

Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in the United States. Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 91 M. pneumoniae--positive specimens from 6 US locations.